JW Asset Management’s Alimera Sciences ALIM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-27,552
Closed -$265K 12
2021
Q1
$265K Hold
27,552
0.08% 10
2020
Q4
$116K Hold
27,552
0.05% 9
2020
Q3
$134K Hold
27,552
0.08% 7
2020
Q2
$174K Hold
27,552
0.12% 8
2020
Q1
$110K Hold
27,552
0.1% 8
2019
Q4
$209K Sell
27,552
-1
-0% -$6 0.15% 8
2019
Q3
$234K Hold
27,553
0.21% 10
2019
Q2
$368K Hold
27,553
0.2% 12
2019
Q1
$438K Hold
27,553
0.22% 15
2018
Q4
$297K Hold
27,553
0.22% 15
2018
Q3
$405K Hold
27,553
0.22% 14
2018
Q2
$404K Sell
27,553
-18,847
-41% -$265K 0.26% 17
2018
Q1
$717K Sell
46,400
-18,000
-28% -$319K 0.71% 18
2017
Q4
$1.28M Hold
64,400
1.37% 16
2017
Q3
$1.3M Hold
64,400
0.96% 22
2017
Q2
$1.34M Buy
64,400
+8,667
+16% +$186K 0.86% 22
2017
Q1
$1.17M Buy
+55,733
New +$1.07M 0.24% 25

Other funds holding ALIM

JW Asset Management's ALIM Position: Q2 2021 in Review

JW Asset Management sold out of Alimera Sciences (ALIM) in Q2 2021, closing a stake of 27,552 shares — an estimated $265K sold.

JW Asset Management first reported a position in ALIM in Q1 2017 and held it in 17 quarters. The position peaked at $1.34M in Q2 2017. 25 funds tracked by Wall St. Rank hold ALIM as of Q2 2021.

  • JW Asset Management reported no remaining Alimera Sciences position as of Q2 2021 after selling out during the quarter.
  • JW Asset Management sold 27,552 Alimera Sciences shares in Q2 2021, an estimated $265K.
  • JW Asset Management first reported a position in Alimera Sciences in Q1 2017 and held it in 17 quarters.
  • JW Asset Management's Alimera Sciences position peaked at $1.34M in Q2 2017.
  • 25 funds tracked by Wall St. Rank held Alimera Sciences as of Q2 2021.

Based on JW Asset Management's 13F filing for Q2 2021, filed 6 Aug 2021.